Geode Capital Management’s PMV Pharmaceuticals PMVP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $459K | Buy |
432,704
+1,912
| +0.4% | +$2.03K | ﹤0.01% | 3583 |
|
|
2025
Q1 | $470K | Buy |
430,792
+9,082
| +2% | +$9.9K | ﹤0.01% | 3564 |
|
|
2024
Q4 | $637K | Sell |
421,710
-11,052
| -3% | -$16.7K | ﹤0.01% | 3535 |
|
|
2024
Q3 | $645K | Buy |
432,762
+5,038
| +1% | +$7.51K | ﹤0.01% | 3512 |
|
|
2024
Q2 | $693K | Sell |
427,724
-475,413
| -53% | -$770K | ﹤0.01% | 3454 |
|
|
2024
Q1 | $1.54M | Buy |
903,137
+42,801
| +5% | +$72.8K | ﹤0.01% | 3215 |
|
|
2023
Q4 | $2.67M | Buy |
860,336
+52,773
| +7% | +$164K | ﹤0.01% | 2999 |
|
|
2023
Q3 | $4.96M | Buy |
807,563
+62,229
| +8% | +$382K | ﹤0.01% | 2647 |
|
|
2023
Q2 | $4.67M | Buy |
745,334
+79,223
| +12% | +$496K | ﹤0.01% | 2722 |
|
|
2023
Q1 | $3.18M | Buy |
666,111
+15,936
| +2% | +$76K | ﹤0.01% | 2830 |
|
|
2022
Q4 | $5.66M | Buy |
650,175
+5,034
| +0.8% | +$43.8K | ﹤0.01% | 2603 |
|
|
2022
Q3 | $7.68M | Buy |
645,141
+79,608
| +14% | +$947K | ﹤0.01% | 2430 |
|
|
2022
Q2 | $8.06M | Buy |
565,533
+113,030
| +25% | +$1.61M | ﹤0.01% | 2408 |
|
|
2022
Q1 | $9.42M | Sell |
452,503
-5,825
| -1% | -$121K | ﹤0.01% | 2383 |
|
|
2021
Q4 | $10.6M | Buy |
458,328
+24,855
| +6% | +$574K | ﹤0.01% | 2405 |
|
|
2021
Q3 | $12.9M | Buy |
433,473
+85,292
| +24% | +$2.54M | ﹤0.01% | 2275 |
|
|
2021
Q2 | $11.9M | Buy |
348,181
+102,095
| +41% | +$3.49M | ﹤0.01% | 2341 |
|
|
2021
Q1 | $8.09M | Buy |
246,086
+242
| +0.1% | +$7.96K | ﹤0.01% | 2507 |
|
|
2020
Q4 | $15.1M | Buy |
245,844
+212,844
| +645% | +$13.1M | ﹤0.01% | 1890 |
|
|
2020
Q3 | $1.17M | Buy |
+33,000
| New | +$1.17M | ﹤0.01% | 3146 |
|